<DOC>
	<DOCNO>NCT02116244</DOCNO>
	<brief_summary>Keratoconjunctivitis sicca ( KCS ) Dry Eye Syndrome disease surface eye , tear film , relate ocular tissue . Millions people suffer one form disease another prevalence increase age . Dry Eye Syndrome sufferer experience broad range symptom include discomfort , irritation , burning , itch , redness , pain , gritty feeling , foreign body sensation , blur vision ocular fatigue . Civamide TRPV-1 receptor modulator cause initial stimulation neuropeptide release subsequent desensitization stimulation trigeminovascular system . This provide pharmacological rational intranasal route administration disorder mediate trigeminal nerve involve cranial nerve . In nine clinical study Civamide Nasal Solution , 50 % nearly 300 patient receive Civamide via intranasal administration experience lacrimation ( tear ) . This lead hypothesis Civamide Nasal Solution might appropriate treatment Dry Eye Syndrome .</brief_summary>
	<brief_title>Civamide Nasal Solution Treatment Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>1 . Patients must age 18 year old . 2 . Patients must document moderate severe evaporative Dry Eye Syndrome least 6 month . 3 . Patients must Schirmer ( anesthesia ) ≤ 8 per 5 minute least one eye Screening Baseline ( Day 1 ) . 4 . Patients must calculate overall score OSDI &gt; 0.1 three response applicable ( N/A ) Screening Baseline ( Day 1 ) . 5 . Patients must normal lid position closure . 6 . Women must postmenopausal ≥ 1 year , surgically sterilize . If , negative urine pregnancy test require within 14 day Day 1 . 7 . Informed consent must provide . 1 . Patients severe inflammatory Dry Eye Syndrome . 2 . Patients Dry Eye Syndrome secondary Sjögren 's Syndrome . 3 . Patients Schirmer ( anesthesia ) &gt; 8 per 5 minute eye . 4 . Patients allergic Civamide similar product , excipients Civamide Nasal Solution 0.01 % . 5 . Patients history previous ocular surgery trauma . 6 . Patients require concurrent ocular medication eye disorder . 7 . Patients use Restasis® , serum tear , oral omega 3 supplement last 30 day oral cyclosporine last 90 day . 8 . Patients receive receive within 30 day experimental systemic medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dry Eye</keyword>
	<keyword>Civamide</keyword>
	<keyword>Zucapsaicin</keyword>
	<keyword>Neuropeptides</keyword>
	<keyword>TRPV-1</keyword>
</DOC>